Alamar Biosciences, Inc. · NASDAQ:ALMR
Qiming GP VIII-HC, LLC converted 10,594,547 Alamar Biosciences, Inc. shares (Form 4)
Traded Apr 20, 2026 · Filed Apr 22, 2026
On Apr 20, 2026, Qiming GP VIII-HC, LLC (10% owner) converted 10,594,547 Alamar Biosciences, Inc. shares, leaving 1,922,329 shares. Filed Apr 22, 2026 (Form 4).
- Converted
- 10,594,547 shares
- Holding after
- 1,922,329 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | Class B Common Stock | Conversion | 185,163 | 185,163 | Indirect | |
| Apr 20, 2026 | Class B Common Stock | Conversion | 6,881,410 | 6,881,410 | Indirect | |
| Apr 20, 2026 | Class B Common Stock | Conversion | 1,605,645 | 1,605,645 | Indirect | |
| Apr 20, 2026 | Class B Common Stock | Conversion | 1,922,329 | 1,922,329 | Indirect | |
| Apr 20, 2026 | Common Stock | Other | 185,163 | 185,163 | Indirect | |
| Apr 20, 2026 | Common Stock | Other | 6,881,410 | 6,881,410 | Indirect | |
| Apr 20, 2026 | Common Stock | Other | 1,605,645 | 1,605,645 | Indirect | |
| Apr 20, 2026 | Common Stock | Other | 1,922,329 | 1,922,329 | Indirect |
Source
Related
- Alamar Biosciences, Inc.
- Qiming GP VIII-HC, LLC
- Alamar Biosciences, Inc. shareholders
- Form 4 · Qiming Corporate GP VI, Ltd. · Oct 23, 2026
- Form 4 · Qiming Corporate GP VI, Ltd. · Oct 21, 2026
- Schedule 13G · Yuling Luo · Aug 13, 2026
- Schedule 13G · Qiming Corporate GP VI, Ltd. · Aug 11, 2026
- Schedule 13D/A · Sands Capital Life Sciences Pulse Fund II, L.P. · Jul 7, 2026